Brought to you by 
NeuTec Pharma nets £24.5mm from follow-on offering
22 May 2006
Executive Summary
NeuTec Pharma (antibody therapeutics for infectious diseases) netted £24.5mm ($45.8mm) through a public offering of about 5.3mm common shares priced at 490 pence ($9.18) each.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NeuTec Pharma nets £24.5mm from follow-on offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice